Skip to content

Application of propofol (-)-noradrenaline in elderly patients undergoing painless gastroscopy

Application of propofol (-)-noradrenaline in elderly patients undergoing painless gastroscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092958
Enrollment
Unknown
Registered
2024-11-26
Start date
2024-12-01
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

digestive system

Interventions

Test Group, :Fentanyl was given 1 ug KG, followed by a propofol (-)-noradrenaline mixture of 0.2 ml kg.
control group:Fentanyl was given 1 ug KG, followed by 0.2 ml kg of propofol and saline mixture.

Sponsors

Tongxiang first People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) all patients met the indication of gastroscopy, (2) age 65-80 years, (3) American Society of Anesthesiologists (ASA) grade i-II, (4) all patients signed informed consent, and (5) compliance was good

Exclusion criteria

Exclusion criteria: (1) severe heart, lung, liver and kidney disease, (2) Coagulopathy, and (3) allergic to (-)-noradrenaline, propofol, fentanyl, etc. . (4) preoperative evaluation of patients with difficult airway (Mallampati grade = III) or sleep apnea syndrome. (5) patients with preoperative blood pressure greater than 180/110 mmhg or SBP less than 90 mmhg

Design outcomes

Primary

MeasureTime frame
mean arterial pressure;systolic pressure;diastolic blood pressure;heart rate;

Countries

CHINA

Contacts

Public Contactzhongjian

Tongxiang first People's Hospital

506133372@qq.com+86 188 5734 7958

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026